Bg pattern

MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Meropenem Steriscience 500 mg powder for injectable and infusion solution EFG

Meropenem Steriscience 1000 mg powder for injectable and infusion solution EFG

Meropenem

Read the entire leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor, pharmacist, or nurse.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Meropenem Steriscience and what is it used for
  2. What you need to know before starting to use Meropenem Steriscience
  3. How to use Meropenem Steriscience
  4. Possible side effects
  5. Storage of Meropenem Steriscience
  6. Package contents and additional information

1. What is Meropenem Steriscience and what is it used for

Meropenem Steriscience contains the active ingredient meropenem and belongs to a group of medications called carbapenem antibiotics. It works by destroying bacteria that can cause severe infections.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or common cold.

It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medications down the drain or in the trash.

Meropenem is used to treat the following infections in adults and children over 3 months of age:

  • Infection affecting the lungs (pneumonia)
  • Bronchial and lung infections in patients with cystic fibrosis
  • Complicated urinary tract infections
  • Complicated abdominal infections
  • Infections that can be acquired during and after childbirth
  • Complicated skin and soft tissue infections
  • Acute bacterial infection of the brain (meningitis)

Meropenem may be used to treat patients with neutropenia who present with fever suspected to be due to a bacterial infection.

Meropenem can be used to treat bacterial infections of the blood that may be associated with one of the aforementioned infections.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Meropenem Steriscience

Do not use Meropenem Steriscience:

  • if you are allergic to meropenem or any of the other components of this medication (listed in section 6);
  • if you are allergic (hypersensitive) to other antibiotics, such as penicillins, cephalosporins, or carbapenems, as you may also be allergic to meropenem.

Warnings and precautions

Consult your doctor or nurse before starting to use this medication if:

  • you have health problems, such as liver or kidney problems;
  • you have had severe diarrhea after taking other antibiotics.

You may test positive for a test (Coombs test) that indicates the presence of antibodies that can destroy red blood cells. Your doctor will discuss this with you.

You may experience signs and symptoms of severe skin reactions (see section 4). If this occurs, inform your doctor or nurse immediately so that they can treat the symptoms.

If you are unsure whether you are in any of these situations, consult your doctor or nurse before using this medication.

Children

This medication is not recommended for use in children under 3 months of age, as the safety and efficacy of meropenem have not been established in children of these ages.

Other medications and Meropenem SteriscienceInform your doctor, pharmacist, or nurse if you are using, have recently used, or may need to use any other medication.

This is because meropenem may affect the way some medications work, and some of these may have an effect on meropenem.

In particular, inform your doctor, pharmacist, or nurse if you are taking any of the following medications:

  • Probenecid (used to treat gout).
  • Valproic acid/sodium valproate/valpromide (used to treat epilepsy). Meropenem should not be used, as it may decrease the effect of sodium valproate.
  • Oral anticoagulant (used to treat or prevent blood clots).

Pregnancy and breastfeeding

Pregnancy

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. It is preferable to avoid using meropenem during pregnancy. Your doctor will decide whether you should use meropenem.

Breastfeeding

It is essential that, before receiving treatment with meropenem, you inform your doctor if you are breastfeeding or plan to breastfeed. A small amount of this medication may pass into breast milk. Therefore, your doctor will decide whether you should use meropenem during breastfeeding.

Driving and using machines

No studies have been conducted on the effects on the ability to drive and use machines.

This medication has been associated with headache and tingling or numbness in the skin (paresthesia). Either of these side effects could affect your ability to drive or use machines.

This medication may cause involuntary muscle movements, which can cause the body to shake rapidly and uncontrollably (convulsions). This is usually accompanied by a loss of consciousness. Do not drive or use machines if you experience this side effect.

Meropenem Steriscience contains sodium

Meropenem Steriscience 500 mg: This medication contains 45 mg of sodium (main component of table salt/cooking salt) per 500 mg dose. This is equivalent to 2.25% of the maximum daily recommended sodium intake for an adult.

Meropenem Steriscience 1000 mg: This medication contains 90 mg of sodium (main component of table salt/cooking salt) per 1000 mg dose. This is equivalent to 4.5% of the maximum daily recommended sodium intake for an adult.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to use Meropenem Steriscience

Follow your doctor's, pharmacist's, or nurse's instructions for administering this medication exactly. If you have any doubts, consult your doctor, pharmacist, or nurse again.

Use in adults

  • The dose depends on the type of infection you have, the area of the body where it is located, and its severity. Your doctor will decide what dose you need.
  • The normal dose in adults is between 500 mg (milligrams) and 2000 mg (milligrams). You will usually be given a dose every 8 hours. However, if your kidneys do not function well, you may receive the dose less frequently.

Use in children and adolescents

  • The dose for children over 3 months and up to 12 years is determined using the child's age and weight. The normal dose is between 10 mg and 40 mg of meropenem per kilogram (kg) of the child's weight. You will usually be given a dose every 8 hours. Children who weigh over 50 kg will be given an adult dose.

How to use Meropenem Steriscience

  • Meropenem will be administered to you as an injection or infusion into a large vein.
  • Meropenem will usually be administered by your doctor or nurse.
  • However, some patients, parents, or caregivers receive training to administer meropenem at home. The instructions for this are found in this leaflet (in the section called "Instructions for administering meropenem to yourself or to another person at home"). Follow your doctor's instructions for administering meropenem exactly. Consult your doctor if you have any doubts.
  • The injection should not be mixed with solutions containing other medications, nor should other medications be added to it.
  • The injection may take approximately 5 minutes or between 15 and 30 minutes. Your doctor will tell you how meropenem is administered.
  • Injections should usually be administered at the same time every day.

If you use more Meropenem Steriscience than you should

If you accidentally use more than the prescribed dose, contact your doctor or go to the nearest hospital immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Meropenem Steriscience

If you forget an injection, you should receive it as soon as possible. However, if it is almost time for your next injection, do not receive the missed one. Do not use a double dose (two injections at the same time) to make up for missed doses.

If you interrupt treatment with Meropenem Steriscience

Do not interrupt meropenem until your doctor tells you to do so.

If you have any other questions about using this medication, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Severe allergic reactions

If you experience any of the following signs and symptoms, inform your doctor or nurse immediately.You may need urgent medical treatment. The signs and symptoms may include a sudden onset of:

  • Severe rash, itching, or hives on the skin.
  • Swelling of the face, lips, tongue, or other parts of the body.
  • Shortness of breath, wheezing, or difficulty breathing.
  • Severe skin reactions, including:
    • Severe hypersensitivity reactions with fever, rash, and changes in blood test results showing liver activity (increased liver enzyme levels), increased eosinophils, and swollen lymph nodes. These may be signs of a multi-organ sensitivity disorder known as DRESS syndrome.
    • Severe scaly red rash, pus-filled bumps on the skin, blisters, or peeling skin, which may be accompanied by high fever and joint pain.
    • Severe skin reactions that may appear as circular red patches — often with central blisters — on the torso, peeling skin, or ulcers in the mouth, throat, nose, genitals, and eyes, which may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome) or a more severe form (toxic epidermal necrolysis).

Damage to red blood cells (frequency not known)

Symptoms include:

  • Shortness of breath when you do not expect it.
  • Red or brown urine.

If you observe any of the above, see a doctor immediately.

Other possible side effects:

Common (may affect up to 1 in 10 people)

  • Abdominal pain (stomach pain).
  • Nausea.
  • Vomiting.
  • Diarrhea.
  • Headache.
  • Rash, itching on the skin.
  • Pain and inflammation.
  • Increased platelet count in the blood (detected in a blood test).
  • Changes in blood tests, including those that show liver activity.

Uncommon (may affect up to 1 in 100 people)

  • Changes in blood, including a decrease in platelet count (which can make you bruise more easily), increased white blood cells, decreased white blood cells, and increased bilirubin. Your doctor may perform periodic blood tests.
  • Changes in blood tests, including those that show kidney activity.
  • Tingling sensation (paresthesia).
  • Mouth or vaginal infections caused by a fungus (thrush).
  • Inflammation of the intestine with diarrhea.
  • Pain in the veins where meropenem is injected.
  • Other changes in blood. Symptoms include frequent infections, fever, and sore throat. Your doctor may perform periodic blood tests.

Rare (may affect up to 1 in 1,000 people)

  • Seizures (convulsions).
  • Sudden confusion and disorientation (delirium).

Reporting side effects

It is essential to report suspected adverse reactions to the medication after its authorization. This allows for continuous monitoring of the benefit-risk ratio of the medication. Healthcare professionals are encouraged to report suspected adverse reactions through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es.

5. Storage of Meropenem Steriscience

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the packaging and on the label of the vials after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Injection

After reconstitution:

Reconstituted solutions for intravenous use should be used immediately.

Chemical and physical stability in use has been demonstrated for the prepared solutions for intravenous injection for the following periods:

  • 3 hours at a maximum of 25 °C;
  • 6 hours under refrigeration conditions (2 °C to 8 °C).

Infusion

After reconstitution:

Reconstituted solutions for intravenous use should be used immediately.

When meropenem is dissolved in 0.9% sodium chloride (9 mg/ml), chemical and physical stability in use has been demonstrated for the prepared solutions for infusion for the following periods:

  • 3 hours stored at a maximum of 25 °C;
  • 24 hours stored under refrigeration conditions (2 °C to 8 °C).

When meropenem is dissolved in 5% glucose (dextrose) (50 mg/ml), the solution should be used immediately.

From a microbiological point of view, unless the reconstitution method rules out the risk of microbiological contamination, the product should be used immediately.

If not used immediately, the storage times and conditions are the responsibility of the user.

Do not freeze the reconstituted solution.

Medications should not be thrown down the drain or in the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Contents of the pack and additional information

Composition of Meropenem Steriscience

The active substance is meropenem.

Each vial contains meropenem trihydrate equivalent to 500 mg or 1000 mg of meropenem.

The other component is sodium carbonate.

Appearance and pack contents of the product

Meropenem Steriscience is a white to pale yellow powder for solution for injection and infusion in a vial.

Meropenem Steriscience 500 mg powder for solution for injection and infusion

Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and sky blue in color.

Meropenem Steriscience 1000 mg powder for solution for injection and infusion

Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and red in color.

The product is available in pack sizes of 1 or 10 vials. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Steriscience B.V.

Kranenburgweg 135-A

2583 ER The Hague

Netherlands

Manufacturer

Pharma Pack Hungary Kft.

H-2040, Budaörs, Vasút út 13

Hungary

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Belgium

Meropenem Steriscience 500 mg powder for solution for injection/infusion

Meropenem Steriscience 1000 mg powder for solution for injection/infusion

Bulgaria

Meropenem 500 mg ????? ?? ???????????/?????????? ???????

Meropenem 1000 mg ????? ?? ???????????/?????????? ???????

Estonia

Meropenem Steriscience

Finland

Meropenem Steriscience 500 mg injektio-/infuusiokuiva-aine liuosta varten

Meropenem Steriscience 1000 mg injektio-/infuusiokuiva-aine liuosta varten

France

Meropenem Steriscience 500 mg poudre pour solution injectable/pour perfusion

Meropenem Steriscience 1000 mg poudre pour solution injectable/pour perfusion

Netherlands

Meropenem Steriscience 500mg, poeder voor oplossing voor injectie of infusie

Meropenem Steriscience 1000 mg, poeder voor oplossing voor injectie of infusie

Croatia

Meropenem Steriscience 500 mg prašak za otopinu za injekciju/infuziju

Meropenem Steriscience 1000 mg prašak za otopinu za injekciju/infuziju

Ireland

Meropenem 500 mg powder for solution for injection/infusion

Meropenem 1000 mg powder for solution for injection/infusion

Italy

Meropenem Steriscience

Iceland

Meropenem 500 mg stungulyfs-/innrennslisstofn, lausn

Meropenem 1000 mg stungulyfs-/innrennslisstofn, lausn

Czech Republic

Meropenem Steriscience

Lithuania

Meropenem 500 mg milteliai injekciniam ar infuziniam tirpalui

Meropenem 1000 mg milteliai injekciniam ar infuziniam tirpalui

Latvia

Meropenem Steriscience, 500 mg pulveris injekciju/infuziju škiduma pagatavošanai

Meropenem Steriscience, 1000 mg pulveris injekciju/infuziju škiduma pagatavošanai

Luxembourg

Meropenem 500 mg Pulver fir Léisung fir Injektioun / Infusioun

Meropenem 1000 mg Pulver fir Léisung fir Injektioun / Infusioun

Hungary

Meropenem Steriscience, 500 mg por oldatos injekcióhoz vagy infúzióhoz

Meropenem Steriscience, 1000 mg por oldatos injekcióhoz vagy infúzióhoz

Malta

Meropenem Steriscience 500 mg powder for solution for injection/infusion

Meropenem Steriscience 1000 mg powder for solution for injection/infusion

Norway

Meropenem Steriscience

Poland

Meropenem Steriscience

Portugal

Meropenem 500 mg pó para solução injetável/perfusão

Meropenem 1000 mg pó para solução injetável/perfusão

Austria

Meropenem Steriscience 500 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung

Meropenem Steriscience 1000 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung

Romania

Meropenem Steriscience 500 mg pulbere pentru solutie injectabila/ perfuzabila

Meropenem Steriscience 1000 mg pulbere pentru solutie injectabila/ perfuzabila

Greece

Meropenem 500 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση

Meropenem 1000 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση

Cyprus

Meropenem 500 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση

Meropenem 1000 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση

Slovak Republic

Meropenem Steriscience 500 mg prášok na injekcný/ infúzny roztok

Meropenem Steriscience 1000 mg prášok na injekcný/ infúzny roztok

Denmark

Meropenem Steriscience

Slovenia

Meropenem Steriscience 500 mg prašek za raztopino za injiciranje/infundiranje

Meropenem Steriscience 1000 mg prašek za raztopino za injiciranje/infundiranje

Spain

Meropenem Steriscience 500 mg polvo para solución inyectable y para perfusión

Meropenem Steriscience 1000 mg polvo para solución inyectable y para perfusión

Sweden

Meropenem Steriscience, 500 mg pulver till injektions-/infusionsvätska, lösning

Meropenem Steriscience, 1000 mg pulver till injektions-/infusionsvätska, lösning

Date of last revision of this leaflet:01 2022

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)

http://www.aemps.gob.es/.

Text on the correct use of antibiotics and prevention of bacterial resistance with numbered tips

This information is intended solely for healthcare professionals:

To consult all the information on administration guidelines, warnings, and precautions, instructions for reconstitution of the medicinal product before administration, etc., see the summary of product characteristics.

Instructions for administering meropenem to yourself or to another person at home

Some patients, parents, and caregivers are trained to administer meropenem at home.

Warning: This medicinal product should only be administered to yourself or to another person at home after a doctor or nurse has trained you.

How to prepare this medicinal product

  • The medicinal product must be mixed with another liquid (the diluent). Your doctor will tell you what amount of diluent to use.
  • Use the medicinal product immediately after preparation. Do not freeze it.
  1. Wash your hands and dry them very well. Prepare a clean work area.
  2. Remove the meropenem vial from the packaging. Check the vial and expiration date. Check that the vial is intact and has not been damaged.
  3. Remove the colored cap and clean the gray rubber stopper with a cotton swab soaked in alcohol. Let the rubber stopper dry.
  4. Insert a new sterile needle into a new sterile syringe, without touching the ends.
  5. Draw up the recommended amount of sterile "water for injections" with the syringe. The amount of liquid you need is shown in the table below:

Meropenem dose

Amount of "water for injections" needed for dilution

500 mg (milligrams)

10 ml (milliliters)

1000 mg

20 ml

1500 mg

30 ml

2000 mg

40 ml

Note:If the amount of meropenem prescribed for you is more than 1 g, you will need to use more than one meropenem vial. You can then draw up the liquid from the vials into a syringe.

  1. Pierce the center of the gray rubber stopper with the syringe needle and inject the recommended amount of "water for injections" into the meropenem vial(s).
  2. Remove the needle from the vial and shake it well for about 5 seconds, or until all the powder has dissolved. Clean the gray rubber stopper again with a new cotton swab soaked in alcohol and let it dry. Before administration, the solution must be visually inspected for particles or color change. Use the solution only if it is transparent, colorless, or yellowish and does not contain particles.
  3. With the syringe plunger fully pushed into the syringe, pierce the gray rubber stopper again with the needle. You must then hold the syringe and vial and turn the vial upside down.
  4. Keeping the needle end in the liquid, pull the plunger and draw up all the liquid from the vial into the syringe.
  5. Remove the needle and syringe from the vial and discard the empty vial in an appropriate container.
  6. Hold the syringe vertically, with the needle facing up. Gently tap the syringe to make any bubbles in the liquid rise to the top of the syringe.
  7. Remove the air from the syringe by gently pushing the plunger until all the air has been removed.
  8. If you are using meropenem at home, dispose of the needles and infusion lines you have used properly. If your doctor decides to interrupt your treatment, dispose of any unused meropenem properly.

Administration of the injection

You can administer this medicinal product through a peripheral intravenous catheter or through a central port or line.

Administration of meropenem through a peripheral intravenous catheter

  1. Remove the needle from the syringe and carefully discard it in authorized containers for sharp objects.
  2. Clean the end of the peripheral intravenous catheter with a cotton swab soaked in alcohol and let it dry. Open the cannula cap and connect the syringe.
  3. Slowly press the syringe plunger to administer the antibiotic constantly over about 5 minutes.
  4. Once you have finished administering the antibiotic and the syringe is empty, remove it and flush the line as your doctor or nurse has recommended.
  5. Close the cannula cap and carefully discard the syringe in authorized containers for sharp objects.

Administration of meropenem through a central port or line

  1. Remove the cap from the port or line, clean the end of the line with a cotton swab soaked in alcohol, and let it dry.
  2. Connect the syringe and slowly press the plunger to administer the antibiotic constantly over about 5 minutes.
  3. Once you have finished administering the antibiotic, remove the syringe and flush the line as your doctor or nurse has recommended.
  4. Place a new clean cap on the central line and carefully discard the syringe in authorized containers for sharp objects.

Each vial is for single use.

The solution must be shaken before use. Before administration, it must be visually inspected for particles or color change. Use the solution only if it is transparent, colorless, or yellowish and does not contain particles.

For the storage conditions after reconstitution/dilution of the medicinal product, see section 5.

The disposal of unused medicinal product and all materials that have come into contact with it will be carried out in accordance with local regulations.

Online doctors for MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Discuss questions about MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58

Frequently Asked Questions

Is a prescription required for MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
The active ingredient in MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is meropenem. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is manufactured by Steriscience B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
Other medicines with the same active substance (meropenem) include ARCHIFAR 1G POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, ARCHIFAR 500 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, MEROPENEM ACCORDPHARMA 1 g POWDER FOR INJECTION AND INFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media